| Financial Year |
March 31 2023 |
| Monetary Funds |
348,155,053.67 |
| Held-for-trading Financial Assets |
43,000,000.00 |
| Notes Receivable |
9,785,906.54 |
| Accounts Receivable |
470,021,234.14 |
| Advances to Suppliers |
35,585,654.23 |
| Other Receivables |
7,726,962.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
756,257,208.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,922,325.66 |
| Total Current Assets |
1,872,559,923.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,369,796,658.12 |
| Investment Properties |
1,727,780.12 |
| Fixed Assetes |
952,169,975.78 |
| Under-construction Projects |
86,822,385.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,582,318.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
71,404.00 |
| Deferred Income Tax Assets |
17,214,576.38 |
| Other Non-Current Assets |
111,011,853.63 |
| Sub-Total of Non-Current Assets |
2,697,378,337.77 |
| Total Assets |
4,569,938,261.66 |
| Short-Term Loans |
249,222,352.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
252,739,448.12 |
| Accounts Payable |
624,993,999.49 |
| Accounts Received In Advance |
906,717.78 |
| Employee Compensation Payable |
44,700,164.53 |
| Taxes Payable |
18,475,085.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,576,951.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
283,584,404.26 |
| Other Current Liabilities |
9,934,977.34 |
| Sub-Total of Current Liabilities |
1,591,502,903.04 |
| Long-term Loans |
379,300,000.00 |
| Bonds Payable |
149,891,888.17 |
| Long-Term Accounts Payable |
5,001,596.86 |
| Special Payable |
-- |
| Estimatied Liabilities |
43,525,211.78 |
| Deferred Income Tax Liabilities |
7,928,676.95 |
| Other Non-Current Liabilities |
86,846,168.86 |
| Sub-Total of Non-Current Liabilities |
708,224,835.96 |
| Total Liabilities |
2,299,727,739.00 |
| Paid-In Capital(Or Share Stock) |
400,060,000.00 |
| Capital Surplus |
860,718,963.52 |
| Surplus Reserve |
116,836,207.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
806,216,022.47 |
| Minority Stockholder's Interest |
86,962,999.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,183,247,523.38 |
| Owner's Equity（Stockholder's Equity） |
2,270,210,522.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,569,938,261.66 |
